does external review actually matter or is it forum lore at this point
does external review actually matter or is it forum lore at this point — that is what I am asking, and I have already read the wiki twice.
Peer-to-peer took fifteen minutes and resolved something a written appeal had been sitting on for a month.
New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.
External review was the thing that finally worked. I did not know it existed until a thread on this board.
Research-use-only material is not approved for human use and nothing here should be read as a recommendation to use it.
best — the order this archive was captured in
A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.
Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.
A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician.
This is the whole method. Answer the criterion they named, not the decision in general.
Disagree with the tone strategy. Anger has never moved a determination; matching the criterion has.
Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.
Spent six weeks arguing in general terms and got nowhere. Two paragraphs quoting their own criteria turned it around in eleven days.
Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.
That criterion is from the previous plan year. The current bulletin has different wording.
Push back: your plan is an employer plan, which changes both the appeal path and who the regulator is.
Cosigning on external review. It is a real mechanism, it is underused, and the deadlines are strict.
Small fix — external review is independent of the plan. The second-level internal appeal is not.
Not convinced. That is a formulary exclusion rather than a prior authorisation denial, and the route to challenge it is different.
a peer-to-peer call is often faster than a written appeal
I would not skip the peer-to-peer. It is often the fastest route and it costs a phone call.
I would not skip the peer-to-peer.
marta_vanhecke is right that this is documentation rather than persuasion. It took me a year to accept that.
Yes. Written, always, even when they tell you a phone call is sufficient.
Yes — quoting their own policy bulletin back at them is far more effective than arguing in general terms.
the denial letter names the criterion, start there
Yes.
Adding the underused one — external review. Independent, binding where it applies, and hardly anybody gets that far.
Employer-sponsored plans may be regulated differently from individually purchased ones, which changes both the appeal route and which regulator hears a complaint.
Agreed. The denial letter tells you which criterion failed, and answering that specific criterion is the entire job.
That advice is jurisdiction-specific and this board spans several. Say where you are.
keep every date, every reference number, every name of a department
Documented eighteen months of what had been tried in a one-page table. That table was the appeal.
prior authorisation criteria change every plan year
Careful — the deadline runs from the date on the letter. Waiting for a call back can cost you the appeal entirely.
ask for the clinical policy bulletin by number
- 1I would not skip the peer-to-peer. It is often the fastest route and it…15 comments in this branch · started by u/marta_vanhecke